Assessment Tool Developed for Predicting Suicide Risk After Self-Harm

MONDAY, July 10, 2023 (HealthDay News) -- A clinical assessment tool has been developed to predict risk of suicide among individuals with episodes of self-harm, according to a study published online June 29 in BMJ Mental Health.
Seena Fazel, M.B.Ch.B., M.D., from the University of Oxford in the United Kingdom, and colleagues developed and validated a predictive model for suicide following self-harm, the Oxford Suicide Assessment Tool for Self-harm (OxSATS), using data from Swedish population-based registers. A total of 53,172 individuals aged 10 years and older with health care episodes of self-harm were split into development and validation samples (37,523 individuals with 391 suicides within 12 months, and 15,649 individuals with 178 suicides within 12 months, respectively). Eleven factors were included in the final model: age, sex, and variables related to substance misuse, mental health and treatment, and history of self-harm.
The researchers indicated that the model to predict suicide was developed using sociodemographic and clinical risk factors; in external validation, the model showed good discrimination (c-index, 0.77) and calibration. Using a 1-percent cutoff, the sensitivity was 82 percent and specificity 54 percent for risk of suicide within 12 months. OxSATS is available as a web-based risk calculator.
"Using a clinical prediction model may assist clinical decision-making and resource allocation," the authors write. "Probability scores, if calibration has been tested and shown to be good, provide one way to stratify risk in a clinically feasible way and underscore safety planning."
Related Posts
Macular Degeneration Can Rob You of Sight: Know the Signs
SUNDAY, Feb. 6, 2022 (HealthDay News) -- Early diagnosis and care can often stop...
Had COVID? You’re 5 Times More Prone to Get It Again If Unvaccinated
THURSDAY, Feb. 17, 2022 (HealthDay News) -- After you have recovered from...
Pasar más tiempo al aire libre podría reducir el riesgo de EM en los jóvenes
JUEVES, 9 de diciembre de 2021 (HealthDay News) -- Los niños que están en riesgo...
Sanofi sigue a Lilly y Novo Nordisk, y reduce los precios de la insulina
VIERNES, 17 de marzo de 2023 (HealthDay News) -- Sanofi Inc. se convirtió el...
